FDA Adverse Event Death Summary report: N

LYRA

MDR report key: 475225 · Received August 4, 2003

Report

Report Number
2184056-2003-00036
Event Type
Death
Date Received
August 4, 2003
Date of Event
June 1, 2003
Report Date
August 4, 2003
Manufacturer
ANGEION CORP.
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

THIS ICD WAS SCHEDULED FOR EXPLANTATION AS A RESULT OF THE ANGEION INITIATED "FIELD ACTION" FOR POSSIBLE PREMATURE BATTERY DEPLETION CONCERNING ALL ANGEION MANUFACTURED LYRA MODEL ICD'S. THE BATTERY VOLTAGE ON THIS DEVICE FELL WITHIN THE RANGE WHERE ANGEION RECOMMENDED EXPLANTATION. HOWEVER, IN 2003, ELA MEDICAL, INC. WAS NOTIFIED THAT THE PT PASSED AWAY SOMETIME IN 2003 BEFORE THIS DEVICE COULD BE EXPLANTED. THE CAUSE OF DEATH IS UNK AT THIS TIME. ELA IS IN THE PROCESS OF GATHERING FURTHER INFO FROM THE PHYSICIAN TO VERIFY IF THE PT'S DEATH IS DEVICE RELATED OR NOT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LYRA IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS ANGEION CORP. 2021 *

Patients

Seq Age Sex Outcome Treatment
1 67 YR Death| R